Chad Cowan's most recent trade in Century Therapeutics Inc was a trade of 19,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 19,500 | 230,306 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | 01 Oct 2024 | 446,250 | 446,250 | - | - | Stock Option (right to buy) | ||
| Century Therapeutics Inc | Chad Cowan | Chief Scientific Officer | 01 Oct 2024 | 74,376 | 210,806 | - | 0 | Common Stock |